Both in Biotechnology
Precision BioSciences vs Inhibikase Therapeutics
Over the past year DTIL returned −5.3% and IKT returned −7.5%; their daily moves had a correlation of 0.26.
DTIL −5.3% IKT −7.5%Growth of $1, one year, split-adjusted
| Metric | DTIL | IKT |
|---|---|---|
| Price | $6.97 | $1.48 |
| Market cap | $192.4M | $206.5M |
| Today | +0.29% | −3.90% |
| 1 month | +10.5% | −26.0% |
| 6 months | −6.4% | −23.3% |
| Year to date | +67.5% | −27.8% |
| 1 year | −14.6% | +0.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $65.1M | $159.0M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 50.9% |
| Short % of float | 9.1% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).